Silagan, Joan F.

HRN: 20-74-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFUROXIME 1.5GM (VIAL)
12/06/2025
12/13/2025
IVTT
1.5g
Q8h
S/P Primary LTCS
Checking Final Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines